AI adoption in pharma drops sharply in the domains that matter most for discovery.
Tim Walberg
Advertisement
Author’s note: Tim Wahlberg is Interim President at CAS, where he led the recent launch of CAS NewtonSM, the science-smart agentic AI built for scientific discovery.
Articles by Tim Walberg
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons
2
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
3
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5